skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Percutaneous Transluminal Angioplasty for Complete Membranous Obstruction of Suprahepatic Inferior Vena Cava: Long-Term Results

Journal Article · · Cardiovascular and Interventional Radiology
 [1];  [2]
  1. Turkiye Yuksek Ihtisas Hospital, Department of Interventional Radiology (Turkey)
  2. Turkiye Yuksek Ihtisas Hospital, Department of Gastroenterology (Turkey)

PurposeTo determine the long-term results of percutaneous transluminal angioplasty (PTA) for a complete membranous obstruction of the suprahepatic inferior vena cava.MethodsPatients (n = 65) who were referred to the interventional unit for PTA for a complete membranous obstruction of the suprahepatic inferior vena cava between January 2006 and October 2014 were included in the study. Thirty-two patients (18 males, 14 females, mean age 35 ± 10.7, range 20–42 years) were treated. The patients presented with symptoms of ascites (88 %), pleural effusion (53 %), varicose veins (94 %), hepatomegaly (97 %), abdominal pain (84 %), and splenomegaly (40 %). Transjugular liver access set and re-entry catheter were used to puncture and traverse the obstruction from the jugular side. PTA balloon dilations were performed. The mean follow-up period was 65.6 ± 24.5 months. The objective was to evaluate technical success, complications, primary patency, and clinical improvement in the symptoms of the patients.ResultsThe technical success rate was 94 %. In two patients, obstruction could not be traversed. These patients underwent cavoatrial graft bypass surgery. There were no procedure-related complications. Clinical improvements were achieved in all patients within 3 months. The primary patency rate at 4 years was 90 %. There was no primary assisted patency. There was no need for metallic stent deployment in the cohort. The secondary patency rate at 4 years was 100 %.ConclusionsPercutaneous transluminal angioplasty for a complete membranous obstruction of the suprahepatic inferior vena cava is safe and effective, and the long-term results are excellent.

OSTI ID:
22645415
Journal Information:
Cardiovascular and Interventional Radiology, Vol. 39, Issue 10; Other Information: Copyright (c) 2016 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
Country of Publication:
United States
Language:
English

Similar Records

Budd-Chiari Syndrome Caused by Obstruction of the Hepatic Inferior Vena Cava: Immediate and 2-Year Treatment Results of Transluminal Angioplasty and Metallic Stent Placement
Journal Article · Fri Nov 15 00:00:00 EST 1996 · Cardiovascular and Interventional Radiology · OSTI ID:22645415

Inferior Vena Cava Rupture Caused by Balloon Angioplasty During the Treatment of Budd–Chiari Syndrome
Journal Article · Tue Oct 15 00:00:00 EDT 2019 · Cardiovascular and Interventional Radiology · OSTI ID:22645415

Use of Nitinol Stents Following Recanalization of Central Venous Occlusions in Hemodialysis Patients
Journal Article · Sun Jul 15 00:00:00 EDT 2007 · Cardiovascular and Interventional Radiology · OSTI ID:22645415